Successful treatment of erectile dysfunction and infertility by venesection in a patient with primary haemochromatosis.
A 36-year-old patient with primary haemochromatosis presented with erectile dysfunction. Laboratory findings revealed reduced levels of luteinizing hormone (0.4 IU/l; normal range 2-12 IU/l), follicle-stimulating hormone (0.1 IU/l; normal range 1-12 IU/l) and testosterone (0.49 microg/l; normal range 2-8.1 microg/l). We made the diagnosis of secondary hypogonadism due to haemochromatosis, which is generally supposed to be irreversible. Due to consequent venesection therapy, levels of ferritin and transferrin saturation could be normalized, and levels of luteinizing hormone and follicle-stimulating hormone increased to normal ranges. Also, testosterone levels became normal and remained so without any androgen substitution. The patient subsequently regained erectile function and potency. This case underlines the fact that a hypogonadotrophic hypogonadism caused by iron overload can be reversed by a consequent venesection therapy.
Hamer
O W
OW
Department of Internal Medicine I, University of Regensburg, Germany.
Gnad
M
M
Schölmerich
J
J
Palitzsch
K D
KD
D000328:Adult; D000728:Androgens / Q000627:therapeutic use; D007172:Erectile Dysfunction / Q000209:etiology* / Q000628:therapy; D005293:Ferritins / Q000097:blood; D005640:Follicle Stimulating Hormone / Q000097:blood; D006432:Hemochromatosis / Q000097:blood / Q000150:complications* / Q000235:genetics / Q000628:therapy*; D006801:Humans; D007006:Hypogonadism / Q000209:etiology; D007248:Infertility, Male / Q000209:etiology* / Q000628:therapy; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D018962:Phlebotomy; D013739:Testosterone / Q000097:blood
D000728:Androgens; D013739:Testosterone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D005293:Ferritins